Literature DB >> 26403232

A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease.

G Pellino1, F Selvaggi2, G Ghezzi3, D Corona3, G Riegler4, G G Delaini5.   

Abstract

The management of Crohn's disease (CD) requires extensive expertise. Many treatment options are available, and surgery still plays a crucial role. In recent years, many medical societies have provided surgeons and gastroenterologists dealing with CD with authoritative guidelines. However, a certain degree of variation can be observed in these papers, and application of guidelines in clinical practice should be improved. The Italian society of colorectal surgery (SICCR) promoted the project reported here, which consists of a think tank of Italian colorectal surgeons to address the surgical aspects of CD management. Members of the society were invited to express their opinions on several items proposed by the writing committee, based on evidence available in the literature. The results are presented, focusing on relevant points. The present paper is not an alternative to available guidelines; rather, it offers a snapshot of the attitudes of SICCR surgeons about the surgical treatment of CD. The management of CD is, by necessity, patient-tailored, and it is based on clinical data and surgeon's preference, but the committee was able to identify some points of major disagreement and suggested strategies to improve quality of available data and acceptance of guidelines.

Entities:  

Keywords:  Crohn’s disease; Guidelines; Inflammatory bowel disease; Surgery

Mesh:

Year:  2015        PMID: 26403232     DOI: 10.1007/s10151-015-1368-4

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  80 in total

1.  Proctocolectomy is associated with a higher complication rate but carries a lower recurrence rate than total colectomy and ileorectal anastomosis in Crohn colitis.

Authors:  T Yamamoto; M R Keighley
Journal:  Scand J Gastroenterol       Date:  1999-12       Impact factor: 2.423

2.  A classification of fistula-in-ano.

Authors:  A G Parks; P H Gordon; J D Hardcastle
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

Review 3.  Factors affecting recurrence after surgery for Crohn's disease.

Authors:  Takayuki Yamamoto
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

Review 4.  Laparoscopy in Crohn's disease.

Authors:  Léon Maggiori; Yves Panis
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-12-01       Impact factor: 3.043

Review 5.  Stapled versus handsewn methods for ileocolic anastomoses.

Authors:  Pui Yee Grace Choy; Ian P Bissett; James G Docherty; Bryan R Parry; Arend Merrie; Anita Fitzgerald
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

Review 6.  Short-term outcomes after laparoscopic ileocolic resection for Crohn's disease. A systematic review.

Authors:  Sebastiaan W Polle; Jan Wind; Dirk T Ubbink; Daan W Hommes; Dirk J Gouma; Willem A Bemelman
Journal:  Dig Surg       Date:  2006-12-12       Impact factor: 2.588

7.  Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study.

Authors:  A Tursi; W Elisei; M Picchio; C Zampaletta; G Pelecca; R Faggiani; G Brandimarte
Journal:  Tech Coloproctol       Date:  2014-06-12       Impact factor: 3.781

Review 8.  Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.

Authors:  Giovanni Latella; Gerhard Rogler; Giorgos Bamias; Christine Breynaert; Jon Florholmen; Gianluca Pellino; Shimon Reif; Silvia Speca; Ian C Lawrance
Journal:  J Crohns Colitis       Date:  2014-04-14       Impact factor: 9.071

Review 9.  Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II).

Authors:  Laurence Egan; Renata D'Inca; Tine Jess; Gianluca Pellino; Franck Carbonnel; Bernd Bokemeyer; Marcus Harbord; Paula Nunes; Janneke Van der Woude; Francesco Selvaggi; John Triantafillidis
Journal:  J Crohns Colitis       Date:  2013-05-07       Impact factor: 9.071

10.  Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group.

Authors:  E J Irvine
Journal:  J Clin Gastroenterol       Date:  1995-01       Impact factor: 3.062

View more
  14 in total

1.  A think tank of the Italian Society of Colorectal Surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: ulcerative colitis.

Authors:  F Selvaggi; G Pellino; G Ghezzi; D Corona; G Riegler; G G Delaini
Journal:  Tech Coloproctol       Date:  2015-09-19       Impact factor: 3.781

Review 2.  Consequences of defensive medicine, second victims, and clinical-judicial syndrome on surgeons' medical practice and on health service.

Authors:  Italia Maria Pellino; Gianluca Pellino
Journal:  Updates Surg       Date:  2015-12-09

Review 3.  Prognostic factors affecting outcomes in fistulating perianal Crohn's disease: a systematic review.

Authors:  G C Braithwaite; M J Lee; D Hind; S R Brown
Journal:  Tech Coloproctol       Date:  2017-06-20       Impact factor: 3.781

Review 4.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

Review 5.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Authors:  G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-14       Impact factor: 3.781

Review 6.  Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.

Authors:  D Bouchard; L Abramowitz; G Bouguen; C Brochard; A Dabadie; V de Parades; M Eléouet-Kaplan; N Fathallah; J-L Faucheron; L Maggiori; Y Panis; F Pigot; P Rouméguère; A Sénéjoux; L Siproudhis; G Staumont; J-M Suduca; B Vinson-Bonnet; J-D Zeitoun
Journal:  Tech Coloproctol       Date:  2017-09-19       Impact factor: 3.781

7.  Strictureplasty for Crohn's disease of the small bowel in the biologic era: long-term outcomes and risk factors for recurrence.

Authors:  M Rottoli; M Tanzanu; C A Manzo; M L Bacchi Reggiani; P Gionchetti; F Rizzello; L Boschi; G Poggioli
Journal:  Tech Coloproctol       Date:  2020-04-18       Impact factor: 3.781

Review 8.  Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis.

Authors:  G Pellino; D S Keller; G M Sampietro; M Carvello; V Celentano; C Coco; F Colombo; A Geccherle; G Luglio; M Rottoli; M Scarpa; G Sciaudone; G Sica; L Sofo; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-03-02       Impact factor: 3.781

9.  Clinical recurrence and re-resection rates after extensive vs. segmental colectomy in Crohn's colitis: a retrospective cohort study.

Authors:  M Handler; I Dotan; J M Klausner; H Yanai; E Neeman; H Tulchinsky
Journal:  Tech Coloproctol       Date:  2016-02-17       Impact factor: 3.781

10.  Video-laparoscopic assessment of the small bowel in Crohn's disease: a comparative study to evaluate surgeons' inter-observer variability.

Authors:  E Garofalo; A Spinelli; G Pellino; K Flashman; M Frasson; M Carvello; N de'Angelis; A Garcia-Granero; M Harper; J Warusavitarne; M Coleman; E Espin; F Selvaggi
Journal:  Surg Endosc       Date:  2020-04-02       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.